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Ar ticle

The islet-resident macrophage is in an inflammatory state
and senses microbial products in blood
Stephen T. Ferris,* Pavel N. Zakharov,* Xiaoxiao Wan, Boris Calderon, Maxim N. Artyomov,
Emil R. Unanue, and Javier A. Carrero

W e examined the transcriptional profiles of macrophages that reside in the islets of Langerhans of 3-wk-old non-obese diabetic (NOD), NOD.Rag1−/−, and B6.g7 mice. Islet macrophages expressed an activation signature with high expression of Tnf,
Il1b, and MHC-II at both the transcript and protein levels. These features are common with barrier macrophages of the lung
and gastrointestinal tract. Moreover, injection of lipopolysaccharide induced rapid inflammatory gene expression, indicating
that blood stimulants are accessible to the macrophages and that these macrophages can sense them. In NOD mice, the autoimmune process imparted an increased inflammatory signature, including elevated expression of chemokines and chemokine
receptors and an oxidative response. The elevated inflammatory signature indicates that the autoimmune program was active
at the time of weaning. Thus, the macrophages of the islets of Langerhans are poised to mount an immune response even at
steady state, while the presence of the adaptive immune system elevates their activation state.
Introduction
An emerging theme in macrophage biology is that each tissue macrophage is adapted to its local environment and provides homeostatic support (Amit et al., 2016). Although all
the tissue macrophages share core gene transcripts, including
the transcription factor Spi1 (PU.1) and cell surface receptors
such as Mertk (Mer) and Fcgr1 (CD64), a comparison of different organs reveals substantial differences that may relate to
a specific function (Gautier et al., 2012). Macrophages share
a common set of enhancers, but these are differentially expressed in a tissue-specific manner, leading to their specialization (Kaikkonen et al., 2013; Lavin et al., 2014). For example,
red pulp macrophages are specialized to dispose of effete red
blood cells by sensing heme and inducing Spic (Haldar et al.,
2014). Understanding how the phenotypic qualities of many
tissue macrophages originate and are influenced by their surrounding tissues is a work in progress.
The pancreas contains distinct resident macrophages in
the exocrine and endocrine regions (Calderon et al., 2015).
In each anatomical site, the macrophages differ in their embryonal origin and in their activation status. In an analysis
performed in C57BL/6 mice, the interacinar macrophages
were found to express genes and cell surface markers that
categorize them as M2-like (anti-inflammatory) and tissue
supportive. In contrast, the macrophages in the islets of Langerhans expressed M1-like transcripts typically associated with
inflammatory macrophages. The islet macrophage has a ho*S.T. Ferris and P.N. Zakharov contributed equally to this paper.
Correspondence to Emil R. Unanue: unanue@wustl.edu; Javier A. Carrero: jacarrer@
wustl.edu
Abbreviations used: FDR, false discovery rate; NOD, non-obese diabetic; PCA, principal component analysis; pDC, plasmacytoid DC; PLN, pancreatic lymph node; qRTPCR, quantitative RT-PCR; ROS, reactive oxygen species.
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meostatic role, as shown in the op/op mouse, which lacks
functional CSF-1 protein. In these mice, the islets lack macrophages and develop poorly (Banaei-Bouchareb et al., 2004;
Calderon et al., 2008, 2015).Also, the islet macrophages are intimately associated with intra-islet vessels and in close contact
with β cells (Calderon et al., 2011). Islet macrophages take up
dense core granules and can present the contents of the islet
granule to islet reactive CD4+ T cells (Vomund et al., 2015).
There has been confusion in the field about the identity
of tissue-resident macrophages and DCs.The main reason has
been the long-standing assumption that expression of CD11c
and high MHC-II were specific markers of DCs and that
high F4/80 was a signature of the macrophage. In fact, CD11c
and MHC-II expression are not definitive markers, many tissue-resident macrophages express CD11c and MHC-II, and
F4/80 levels vary across the macrophage lineage. Recent data
have identified more faithful markers for both cells. In the
case of macrophages, the cell surface receptors MerTK and
FcγRI are among the most reliable markers (Gautier et al.,
2012). In the case of DCs, the conventional DCs are best
defined by a group of genes that includes Zbtb46 and Flt3,
while the plasmacytoid DC (pDC) lineage is best defined by
expression of B220, PDCA, and SiglecH (Miller et al., 2012).
The islet macrophages are positive for expression of canonical
macrophage proteins or genes such as MerTK, FcγRI, and
Sfpi1 but do not express the DC markers Zbtb46, Flt3, B220,
and Siglec H (Ferris et al., 2014; Calderon et al., 2015).
Comparing the islet macrophages from nondiabetic
mice with early prediabetic mice is important. The macro© 2017 Ferris et al. This article is distributed under the terms of an Attribution–Noncommercial–Share
Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org
/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
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Results
Core features of the NOD, NOD.Rag1−/−, and B6.g7
islet-resident macrophages
We isolated 3-wk-old islet macrophages (CD45+F4/80+MHC-II+) using the gating strategy shown in Fig. S1 A. Note
that 85–95% of the CD45+ cells in the islets of the 3-wk-old
NOD mice are macrophages; the remaining cells are mostly
CD3ε+ T cells (see also Melli et al., 2009). (Previous work
showed that islets at 3 wk or earlier contained B cells, neutrophils, and pDCs [Diana et al., 2013; Diana and Lehuen, 2014].
However, our experimental analysis did not reproduce these
findings [Figs. S2 and S3].)
We compared macrophages isolated from NOD, NOD.
Rag1−/−, and B6.g7 mice pancreatic islets for their gene expression profiles by RNA sequencing (RNASeq) and cell
surface marker expression. Examination of the NOD.Rag1−/−
and B6.g7 mice established their basal features independent of
autoimmune inflammation. All mice used in this study were
housed in an advanced pathogen-free barrier facility, developed normally, and did not have any indication of infections.
2370

We also included lung macrophages and pancreatic LN
(PLN) XCR1+ DCs (CD45+CD11c+MHC-II+CD172aneg
CD11bnegXCR1+) for additional comparisons (Fig. S1, B
and C). A preliminary analysis of the islet macrophage data
using the Immunological Genome Project (ImmGen) My
GeneSet tool showed that the lung and intestinal macrophages most closely resembled those of the islet (Heng et
al., 2008). We chose the lung macrophage to determine both
common and unique gene expression signatures of the islet
macrophage when compared with other tissue macrophages.
(There are two annotated lung macrophages in ImmGen:
the “lung CD11b+ macrophage” that is CD11bhiCD11c+MHC-II+CD103negCD24neg and the “lung macrophage” that
is CD11c+MHC-IInegCD11bnegCD103negSiglecF+. Our preliminary analysis showed high similarity between the islet
macrophage and the “lung CD11b+ macrophage,” leading us
to examine that population.) The XCR1+ DCs represent a
different phagocyte lineage that is highly relevant for the initiation of diabetes (Ferris et al., 2014). The absence/paucity
of these DCs in islets at the 3-wk window made it difficult to analyze them, so instead we isolated them from the
PLN on the basis of their expression of XCR1. This combination of tissues and cell types allowed us to interrogate
several questions about the transcriptional profile and biology
of the islet macrophage.
The top expressed transcripts in 3-wk-old islet macrophages showed similar values (Fig. 1, A–C). Housekeeping
genes, such as transcriptional regulators and cell structural
genes (i.e., Actb, Fosb, and Hspa5), were comparably expressed (Fig. 1 A and Table S1). Most canonical myeloid
genes were comparably transcribed in both islet macrophages
and in PLN DCs (Fig. 1 B; Gautier et al., 2012). Included
in this group were the MHC-II antigen presentation genes
H2-Aa, H2-Ab1, H2-Eb1, and Cd74. The islet macrophages
do not initially express uniformly high MHC-II on their surface (Calderon et al., 2015). At 2 wk of age, they have varying levels of MHC-II on their surface. However, by 4 wk
of age, MHC-II expression becomes uniformly high (Fig. S1
D). Unlike DCs, high expression of MHC-II genes is not a
basal condition in all tissue-resident macrophages. Microglia,
the large peritoneal macrophages, and alveolar macrophages
express low levels of MHC-II genes and the master regulator
Ciita (Fig. S1 E shows data from ImmGen).
Three additional classes of genes integral to the initiation of an adaptive immune response were expressed highly
in islet macrophages: (1) costimulatory molecules, (2) pattern recognition molecules (TLRs), and (3) chemokines
(Fig. 1, D–G). (1) The most notable costimulatory genes
were the activating ligands Cd86 and Pvr (CD155) and the
inhibitory ligands Lgals9 (Galectin-9) and Cd274 (PD-L1;
Fig. 1 D). (2) Most TLR genes and adaptor proteins were
expressed at high levels, including Tlr1, Tlr2, Tlr3, Tlr4,
Tlr6, Tlr7, Tlr8, Tlr9, Tlr12, and Tlr13, allowing the islet
macrophages to sense different microbial patterns (Fig. 1 E;
Kawai and Akira, 2011; Oldenburg et al., 2012; Koblansky
Transcriptional signatures of islet macrophages | Ferris et al.
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phages constitute the majority of the leukocytes found in islets at steady state, and they can act as a potential modulator
of T cell activation in vivo. Our studies therefore focus on the
3-wk-old mouse, a time before there is overt lymphocytic
infiltration of islets. Overall, the role of the macrophage in
the autoimmune diabetic process is not well understood. In
the non-obese diabetic (NOD) mouse, a strain that develops
spontaneous diabetes, the first inflammatory transcriptional
signatures that can be detected can be mapped back to myeloid cells generally and macrophages specifically (Carrero et
al., 2013). At this early stage in NOD diabetogenesis, a second myeloid cell, the Batf3-dependent XCR1+ DC, enters
the islets, but the relationship between the two cells is not
known. The importance of myeloid cells in diabetogenesis is
reinforced by the finding that the NOD.Batf3−/− mice lacking XCR1+ DCs never develop diabetes (Ferris et al., 2014).
Islet macrophages from two strains of nondiabetic mice
were in an activated state comparable with other barrier
macrophages, such as those found within the lung and the
intestine. They expressed high MHC-II, TNF, and IL-1β, all
at the transcript and protein level, as well as a host of other
inflammatory mediators and sensors. Importantly, the islet
macrophages are sampling blood contents, as there was increased expression of inflammatory transcripts after treatment
with intravenous LPS. In the NOD mouse, the islet macrophage was sensitive to the presence of an adaptive immune
system, having an increased expression of inflammatory transcripts. Interferon-inducible gene signatures were identified
in macrophages from 3-wk-old NOD mice, clearly indicating that the diabetic process was already under way very
early in the life of the mouse. Finally, in a deeper analysis of
the islet macrophages, a quarter of the NOD macrophages
had increased inflammatory transcripts, higher than those
found in the basal state.

Downloaded from jem.rupress.org on September 5, 2017

Figure 1. Transcriptional profiling of islet-resident macrophages. Top expressed housekeeping (A) and myeloid (B) genes from NOD, NOD.Rag1−/−, and
B6.g7 islet macrophages and DCs. Macrophages and DCs were isolated as indicated in Fig. S1. (C) Core macrophage-specific gene signature (as defined by
Gautier et al., 2012), distinguishing macrophages from DCs. Expression of costimulatory genes (D), genes encoding TLRs and adaptors (E), chemokines (F),
JEM Vol. 214, No. 8
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NOD islet macrophages expressed higher levels of
inflammatory transcripts than NOD.Rag1−/− at 3 wk of age
We compared the gene expression profiles of the NOD, NOD.
Rag1−/−, and B6.g7 islet macrophages, the CD11b+ lung macrophage, and the XCR1+ DC. Principal component analysis
(PCA), based on the top 5% of gene expression variance, clustered the islet macrophages tightly along the first and second
components and related them more closely to the CD11b+
lung macrophage than to the PLN XCR1+ DCs (Fig. 2 A).
Pearson correlation and hierarchical clustering reinforced this
point, demonstrating the similarity between NOD, NOD.
Rag1−/−, and B6.g7 macrophages (Fig. 2, B and C).

The NOD macrophage at 3 wk contained an activation
signature when compared with the NOD.Rag1−/− macrophage. Using DESeq2, we found 542 genes differentially expressed at twofold counts (adjusted P ≤ 0.05; Fig. 2, D and
E). Of these, 314 were up-regulated in NOD and 228 were
up-regulated in NOD.Rag1−/− (Fig. 2 D).
By hypergeometric analysis, the major Gene Ontology (GO) pathways enriched in NOD-up-regulated genes
mapped to signal transduction, cellular biosynthetic process, inflammatory response, response to external stimulus,
and defense response (Fig. 2 F). The top C2 pathways (curated gene sets) enriched in NOD macrophages mapped
to KEGG oxidative phosphorylation, KEGG Huntington’s
disease, Naba matrisome associated, and KEGG cytokine/
cytokine receptor interaction (Fig. 2 F; Kanehisa and Goto,
2000; Mootha et al., 2003).
We performed gene set enrichment analysis (GSEA)
using Broad Institute software (Subramanian et al., 2005),
and this revealed a correlation of the NOD-up-regulated
genes with the GO MSigDB biological process gene signatures that associate with oxidative phosphorylation, inflammation, cellular response to reactive oxygen species (ROS),
and cell proliferation (Fig. 2 G; P < 0.002 and false discovery
rate [FDR] q < 0.05: response to oxidative stress [GO term:
0006979], behavior [GO term: 0007610], and inflammatory
response [GO term: 0006954]).
These findings show that the NOD macrophages are
transcriptionally and metabolically more active than their
NOD.Rag1−/− counterparts. First, the behavior and inflammatory response grouping contained NOD-up-regulated
genes involved in chemotaxis, including the chemokine receptors Ccr1 and Ccr7 as well as the chemokines Ccl5, Cxcl2,
and Cxcl9 (Fig. 2, H and I). Second, the islet macrophages
displayed an up-regulation of interferon-inducible genes,
including Cxcl9 and Ccl5, along with early innate immune
mediators such as Cd40 (Fig. 2, H and I). A majority of these
genes are associated with pathogen-associated molecular pattern signaling and are discussed in greater detail in a later
section. Third, the response to oxidative stress signature contained up-regulated genes encoding proteins with an antioxidant role in cells (Fig. 2 J). For example, Sod1 encodes
superoxide dismutase 1, one of two enzymes responsible for
converting superoxide radicals to molecular oxygen and hydrogen peroxide (Fridovich, 1995). Prdx2 and Prdx5 encode
peroxiredoxin 2 and peroxiredoxin 5 antioxidant enzymes,
which reduce hydrogen peroxide and alkyl hydroperoxides
(Wood et al., 2003). Finally, the oxidative phosphorylation
gene signature contained genes whose products are components of the four major complexes of the mitochondrial
electron transport chain as well as the ATP synthase complex

and chemokine receptors (G) by islet macrophages and PLN DCs. Costimulatory gene selection was based on Chen and Flies (2013). TLR and TLR adaptors
were based on Chevrier et al. (2011). Chemokines and chemokine receptors were based on Griffith et al. (2014). Data are the mean of three or four samples
per group and are represented as the log2 global expression level.
2372
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et al., 2013). In contrast, the XCR1+ DCs had reduced or
absent expression of most of the TLRs, except Tlr3, Tlr9,
and Tlr11. (3) Chemokine expression consisted of genes
capable of attracting myeloid cells (Ccl3, Cxcl14), macrophages (Ccl9, Cxcl14), neutrophils (Cxcl1, Cxcl2), NK cells
(Ccl3), NKT cells (Cxcl16), T cells (Ccl4, Cxcl9, Cxcl10,
Cxcl16) and regulatory T cells (Cxcl9; Fig. 1 F; Matloubian
et al., 2000; Kurth et al., 2001; Dufour et al., 2002; Zhao et
al., 2003; Castellino et al., 2006;Yamada et al., 2012; Griffith
et al., 2014). Finally, islet macrophages expressed chemokine receptors found in inflammatory leukocytes (Ccr2,
Ccr5), developing leukocytes (Cxcr4), barrier macrophages
(Ccr2, Ccr5, Ccrl2, Cx3cr1, Cxcr4), and microglia (Cx3cr1)
but whose combined pattern of expression most resembled barrier macrophages (Fig. 1 G; Gautier et al., 2012;
Griffith et al., 2014).
Several myeloid genes were differentially expressed in
the islet macrophages compared with the PLN DCs. Among
these were Atf3, Rasgef1b, and Rgs1 (Fig. 1 B). Atf3 is downstream of TLR4 signaling and acts as a negative regulator of
cytokine transcript expression after LPS treatment (Gilchrist
et al., 2006). Rasgef1b encodes a guanine-nucleotide exchange factor induced by TLR signaling and believed to
activate Ras-like proteins (Andrade et al., 2010). Rgs1 encodes a regulator of G-protein-coupled signaling that antagonizes chemokine receptor signaling (Reif and Cyster,
2000; Moratz et al., 2004). Genome-wide association studies
have linked Rgs1 to celiac disease and type 1 diabetes, but
its exact function in autoimmunity is poorly defined (Smyth
et al., 2008). All three of these genes (Atf3, Rasgef1b, and
Rgs1) are also highly expressed in lung and intestinal macrophage (Heng et al., 2008).
For validation purposes, we identified several cell surface receptors using the Panther classification system (Mi
et al., 2013, 2016). In this way, CD44, CD53, CD83, and
TLR-7 were identified and validated by flow cytometry, as shown in Fig. S1 F.
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(Fig. 2 K). Combined, these findings point to an increase in
the oxidative activity of the NOD macrophages compared
with those of the NOD.Rag1−/− macrophages.

Figure 2. Analysis of islet macrophage transcriptional diversity. (A) PCA of the 5% of genes with the greatest variability for XCR1+ DCs, NOD CD11b+
lung macrophages, and NOD, NOD.Rag1−/−, and B6.g7 islet macrophages. (B) Pearson’s correlation matrix of macrophages and DCs on the basis of all expressed RNASeq probes. (C) Hierarchical clustering of macrophages and DCs for the top 5% of genes with the greatest variability. (D) Scatterplots of expression values of all annotated genes. (E) Heat map of differentially expressed genes taken from D. Each dot represents the mean of four independent biological
replicates for NOD and three for NOD.Rag1−/− conditions. Numbers in plots indicate probes with a DESeq2-calculated fold change between conditions of ≥2
and adjusted P ≤ 0.05 at an FDR of 5% (red, up-regulated in NOD; blue, up-regulated in NOD.Rag1−/−). (F) GO and canonical (C2) pathway hypergeometric
analysis of the genes differentially expressed between NOD and NOD.Rag1−/− islet macrophages. (G) Enrichment plots from GSEA analysis performed on
differentially expressed genes using GO biological process (MSigDB C5BP) signature gene sets. ES, enrichment score. Heat maps of core enrichment genes
from “inflammatory response” (H), “behavior” (I), “response to oxidative stress” (J), and “oxidative phosphorylation” (K) gene sets, identified by either GO (F)
or GSEA (G). Heat maps show individual samples and represent the log2 row normalized expression.
2374
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NOD macrophages at 3 wk of age already display
transcriptional signatures of diabetes progression
We examined whether transcripts found during diabetes progression might be up-regulated in the 3-wk-old
NOD macrophage (Fig. 3 A). We did this by comparing
the islet macrophage transcriptional signature to our previous chronological analysis of whole islets in NOD diabetes (Carrero et al., 2013). Our previous dataset contains
the whole-islet transcriptional analysis of type 1 diabetes
progression in the NOD mouse from 2 wk of age until
the onset of diabetes (∼20–30 wk). This dataset also included control samples from mice that never developed
diabetes: B6.g7, C57BL/6, and NOD.Rag1−/−. We calculated Pearson’s correlation of whole-islet transcriptomes
on the basis of the transcripts differentially up-regulated
in NOD macrophages (the 314 genes described in Fig. 2,
D and E; adjusted P ≤ 0.05 and maximum likelihood estimate–adjusted fold change ≥2). Those same 314 genes
were used to calculate Pearson’s correlation between
whole-islet transcriptomes that ranged between 2 wk
of age and diabetic onset. We found a gradually increasing and positive correlation from 2 wk to diabetic onset
(Fig. 3 A and Fig. S4 A).
The up-regulated transcripts parsed into two clusters
that showed significant enrichment in the MSigDB Canonical (C2) and GO biological pathways (C5BP) databases
(Fig. 3 B). Cluster I included genes that are progressively
up-regulated during NOD diabetes (e.g., Cxcl9, S100a4,
and Ptgs2). These were enriched by hypergeometric test
for inflammatory pathways, namely, defense response, immune system process, and cytokine/cytokine receptor interaction (Fig. 3 C and Fig. S4 B). Cluster II, in contrast,
consisted of genes enriched in developmental pathways,
such as cellular biosynthetic process, translation, and oxidative phosphorylation. These genes were up-regulated in
the islets of 2-wk-old mice and recently diabetic NOD
mice (Fig. 3, B and D; and Fig. S4 C). These transcripts
indicate increased cellular activity, likely accountable by
some level of replication.

Inflammatory transcripts in the islet macrophage are the
hallmark features of a barrier macrophage
GSEA of the genes differentially expressed between NOD
and NOD.Rag1−/− (Fig. 2 G) revealed a correlation with
gene signatures identified in cultured bone marrow–derived
macrophages treated with LPS (dataset: GSE14769 samples,
unstimulated vs. 40-min LPS bone marrow–derived macrophages dominant-negative (Litvak et al., 2009). Similar
findings were made interrogating datasets from macrophages
treated with different inflammatory stimuli. In total, we found
a significant enrichment score for genes expressed after LPS,
TNF, and IL-1 treatment of macrophages (Fig. 4 A).
When further compared with ImmGen datasets, the
macrophages that displayed genes up-regulated in an LPS signature were all barrier macrophages and exposed to either intestinal or airborne stimuli.This association was revealed both
by hierarchical clustering (Fig. 4 B) and by correlation analysis. Both techniques grouped the intestinal and CD11b+ lung
macrophages together and showed that barrier macrophages
as a group had a higher enrichment score for LPS signatures
than the nonbarrier macrophages (Fig. S4 D).
Gene signatures induced by LPS, TNF, and IL-1 were
found highest in the CD11b+ lung macrophage, NOD, NOD.
Rag1−/−, and B6.g7 islet macrophages but not in the bone
marrow macrophage (Fig. 4, C and D). This indicated that at
steady state, the islet macrophages were in an activated state
comparable with those at a barrier surface.
The similarities between the islet-resident macrophage
and barrier macrophages led us to compare our own gene
expression profiles between the islet and the CD11b+ lung
macrophage to identify islet macrophage–enriched signatures.
The top statistically significant canonical signature by GSEA
that distinguished the islet macrophage from the CD11b+
lung macrophage was lysosome (FDR < 1.0E-5, P < 1.0E5; Fig. 4, E and F). The lysosome signature included genes
encoding eight cathepsins (A/B/C/D/H/O/S/Z), Laptm4b,
Laptm4a (lysosomal protein transmembrane 4 alpha and beta),
and Lgmn (legumain cysteine protease). This gene signature
suggested a higher lysosomal activity in the islet macrophages
than in the CD11b+ lung macrophages (Fig. 4 F; Ewald et
al., 2011). The lysosomal gene signature was found in all islet
datasets, indicating that heightened lysosomal function was a
steady-state feature of islet macrophages.

Inflammatory mediator production by the islet macrophages
Intracellular flow cytometry showed production of IL-1β
and TNF, confirming the RNASeq analysis (Fig. 5 A). About
half of the NOD.Rag1−/− islet macrophages were producing
detectable levels of TNF and IL-1β without any stimulation.
Activation with PMA and ionomycin led to limited increases
in TNF and IL-1β proteins, revealing that they were at or
near maximal production (Fig. 5, A and B). For comparison,
the CD11b+ lung macrophage produced almost no detectable TNF but equivalent IL-1β (Fig. 5, A and B). Even when
pulsed with PMA/ionomycin, CD11b+ lung macrophage
TNF cytokine production never reached that of steady-state
islet macrophage levels (Fig. 5 B). Their production of IL-1β
protein was equivalent to the islet macrophages and did not
increase when pulsed with PMA/ionomycin (Fig. 5, A and B).
JEM Vol. 214, No. 8

Activation of IL-1β from its pro form to its active form
requires processing by an active inflammasome-family caspase
(Dinarello, 2009). Islet macrophages from NOD and NOD.
Rag1−/− expressed a detectable level of active caspase-1 when
examined with the fluorescent form of the caspase substrate
YVAD.The CD45-negative fraction (i.e., the endocrine cells)
was negative (Fig. 6 A).
The data indicate that the islet macrophages are making some level of both active IL-1β and TNF. Because both
receptors converge on the NF-κB pathway, we analyzed our
transcriptional data, searching for NF-κB family members
expressed in the whole islet. The only members of the transcription factors and coactivators contained in the NF-κB
and Rel family detectable above background were Nfkb1
(p105/p50) and Rela (p65; Carrero et al., 2013). Therefore,
2375
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Figure 3. Early inflammatory signature during diabetogenesis. (A) Pearson’s correlation of samples from Carrero et al. (2013) on the basis of genes
identified using DESeq2 as differentially up-regulated in NOD versus NOD.Rag1−/− macrophages with adjusted P ≤ 0.05 and fold change ≥2. (B) Hierarchically clustered genes from A in whole-islet transcriptome analysis (top). The Z-score profiles of genes expression in cluster I (red) and cluster II (green) are
shown (bottom). Sample number ranged from three to six per group. Each column represents data obtained from one biological replicate each composed
of all the intact islets isolated from one mouse of the indicated genotype. (C and D) Hypergeometric analysis of the genes identified in clusters I and II in B
using GO biological pathways and C2 canonical pathways.
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Figure 4. Islet macrophages are similar to barrier macrophages. (A) GSEA enrichment plots of NOD versus NOD.Rag1−/− islet macrophage differences
on the basis of LPS, TNF, and IL-1 signatures. The differences between NOD and NOD.Rag1−/− were compared with published signatures of LPS, TNF, and IL-1
cells as described in Materials and methods. ES, enrichment score. (B) Hierarchical clustering of ImmGen microarray data for macrophages from different
tissues. The LPS signature genes were selected for clustering the macrophage microarray data from ImmGen. Heat map shows the log2 row normalized
expression. (C) LPS, TNF, and IL-1 signatures from bone marrow and lung (CD103negCD11b+) macrophage microarrays (ImmGen), and lung and islet macro2376
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we examined the nuclear localization of the NF-κB component RelA/p65 (Rütti et al., 2016). Staining for RelA/
p65 revealed a predominantly cytosolic pattern of staining in
NOD islets at 6 wk of age (Fig. 6 B, top). As a positive control, islet cells treated with IL-1β induced nuclear localization
(Fig. 6 B, bottom). Therefore, despite the expression of IL-1β
and TNF by islet macrophages, there was limited detectable
nuclear NF-κB in the endocrine pancreas.These data indicate
that despite the levels of cytokine being made by the islet
macrophages, the β cells are not strongly signaling.

Single-cell analysis of islet macrophages reveals
heterogeneity in the NOD but not the NOD.Rag1−/− mice
We examined if the inflammatory gene expression differences
between NOD and NOD.Rag1−/− islets was due to homogeneous or heterogeneous autoimmune activation of the NOD
macrophages. To interrogate transcriptional heterogeneity at
the cellular level, we examined individual macrophages from
NOD and NOD.Rag1−/− islets. Macrophages were sorted
directly into RNA lysis buffer, cDNA was synthesized and
preamplified, and qRT-PCR was performed for 95 different
markers using the Fluidigm Biomark HD system.The starting

Discussion
We made three key findings that place the resident macrophage in a unique position to regulate islet function. First, the
islet macrophages are in an activated state comparable with
macrophages exposed at barrier surfaces. This result leads to
the obvious question: why are these macrophages in such a
state? The islet is a mini-organ that is constantly responding
to several stimuli that vary and oscillate, such as blood glucose,
the most prevalent bioactive molecule. We have reported that
the macrophages capture dense core granules and therefore
must be exposed to the products of the β cell (Vomund et al.,
2015).We also showed here how blood products, in our example a low dose of LPS, were accessible to the islet macrophage.
In a previous paper, we indicated that the islet macrophages
extended filopodia into the blood vessel lumen, which could
be the interacting structure with the circulation (Calderon et

phages from the present study. All expressed genes were ranked by expression level, and genes that match to the signatures are depicted as horizontal lines.
(D) Schematic illustration of expression levels of the LPS, TNF, and IL-1 signatures genes in different macrophages. (E) GSEA enrichment plot of the lysosome
gene pathway, the top canonical (C2, MSigDB) pathway up-regulated in islet macrophages when compared with CD11b+ lung macrophages. (F) Heat map
of the core enrichment genes from E. Heat map shows individual samples and represent the log2 row normalized expression.
JEM Vol. 214, No. 8
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Islet macrophages respond to blood-borne stimuli
A blood-borne stimulus might be able to induce part of activation profile in the macrophage, as suggested by the expression of Tnf, Il1a, and Il1b transcripts. This idea is supported
by our previous finding that the islet macrophage extended
filopodia into the lumen of the blood vessel and could interact with blood-borne particles (Calderon et al., 2011).
To determine if a blood-borne TLR-agonist could stimulate the islet macrophage, we injected LPS at low concentrations that would not induce systemic effects. LPS was injected
intravenously into 3-wk-old NOD and NOD.Rag1−/− mice.
Islets were isolated 3 h later, and the islet macrophage was
sorted using the strategy outlined in Fig. S1. Transcripts associated with signaling of TLR4 were assayed using quantitative RT-PCR (qRT-PCR). The transcripts for Cxcl9, Ccl5,
Il12b, Nos2, and Il6 were significantly up-regulated after LPS
injection of NOD.Rag1−/− mice when compared with control PBS-injected mice (Fig. 6 C). Cxcl9, Ccl5, and Il12b
were up-regulated in the NOD mice. Notably, the NOD
mice displayed higher baseline expression than the NOD.
Rag1−/− mice for all markers examined. This was not surprising, as some of these markers were the most differentially
expressed between NOD and NOD.Rag1−/− mice by RNASeq (Fig. 2 D). In sum, the islet macrophage is accessible and
reacting to circulating LPS, a strong representative pathogen-associated molecular pattern.

cell inputs were 184 NOD and 95 NOD.Rag1−/− macrophages. After outlier detection using Singular analysis software, 143 NOD and 79 NOD.Rag1−/− macrophages were
kept for further analysis.
By PCA, the majority of macrophages from both mice
clustered together, except for a subset in the NOD samples
represented by 42 of 184 (22.8%; outlined in Fig. 7 A). The
combination of ANOVA and fold change analysis was performed on the normalized expression values (log2ex) of the
single macrophage PCR data (Fig. 7 B). We identified several
genes previously shown to be differentially expressed between
NOD and NOD.Rag1−/− samples by RNASeq, including
Ccl5, Cxcl9, Ly6a, Cd38, and Dnase1l3. However, Cxcl9 was
the most significant differentially expressed gene. All of the
cells contained in the NOD outlier population expressed high
levels of Cxcl9. The population level macrophage RNASeq
data showed that Cxcl9 was the most differentially expressed
gene between the NOD and NOD.Rag1−/− samples, and the
expression of this chemokine was detected only in the NOD
outlier population (Fig. 2 D and 7 A and Table S1). In total, 26
of 95 genes interrogated by single cell qRT-PCR were differentially expressed between NOD and NOD.Rag1−/− samples
at twofold change and P < 0.01. Selection of these genes
revealed a cluster enriched in only NOD but not NOD.
Rag1−/− samples (Fig. S5 A, left side of the heat map; for the
heat map of the entire dataset, see Fig. S5 B).
In brief, the islet-resident macrophages in the NOD.
Rag1−/− mouse were homogeneous. In the NOD mouse at
3 wk, there was heterogeneity in their activation state. There
was a major set identical to the NOD.Rag1−/− macrophage
but also a second that expressed the same up-regulated transcripts revealed by the RNASeq analysis.

Figure 5. Flow cytometric evaluation of
islet macrophages for transcriptionally
identified markers. (A) The islets and lungs
of 3-wk-old NOD and NOD.Rag1−/− mice
were isolated and single-cell suspensions
were made. Cells were stained with antibodies against cell surface markers and then fixed
and stained with antibodies against intracellular pro-form IL-1β and TNF. Plots were gated
on CD45+CD11c+MHC-II+CD11b+F4/80+. The
percentages of cells positive are indicated in
each quadrant. Results are representative of
three independent experiments per condition.
(B) Graphs of the percentage of macrophages
positive for either TNF or IL-1β as determined
in A. Bars show the mean ± SD for at least
three independent experiments per condition.
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cell–deficient mice (µMT) display decreased incidence and
penetrance of diabetes (Greeley et al., 2002).
The third finding is that there are genes characteristic of
diabetes progression being expressed in 3-wk-old islet macrophages. This implies that even without overt lymphocyte
infiltration of the islet or destruction of β cells, the adaptive
immune system is enforcing a degree of activation on the
islet macrophage. Thus, superimposed on the basal activation
state, the diabetes susceptible traits impose a further activation program that is likely to be critical for the development
and progression of the disease. The single-cell analysis of the
islet-resident macrophages showed that only a subset of the
NOD macrophages were more inflamed than those of the
NOD.Rag1−/−. We cannot conclusively state which signal/
cell type is responsible for the activation of the macrophage
in a young NOD mouse, but the presence of an interferon
signature points to an activated diabetogenic T cell acting on
the islets at these early times. We have found a few T cells
in islets at this early time period (Carrero et al., 2013). Also,
up-regulation of the oxidative phosphorylation in NOD
macrophages, as well as self-defense antioxidant enzyme expression (response to oxidative stress, GO term 0006979),
suggests antimicrobial generation of ROS. Higher ROS synthesis in NOD macrophages compared with NOD.Rag1−/−
Transcriptional signatures of islet macrophages | Ferris et al.
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al., 2011). In essence, the islet macrophages may be activated
by intra-islet components as well as by blood products.
A second finding, as mentioned above, is the capacity
of the islet macrophages to sense blood-borne stimuli. This
finding opens the question of the biological significance of
such sensing as well as on the repertoire of stimulants, an issue
that needs critical evaluation. One needs to keep in mind
that the Tlr2−/−, Tlr9−/−, and Myd88−/− mice have reduced
incidences of diabetes (Kim et al., 2007; Wen et al., 2008; Tai
et al., 2016). It is tempting to postulate that during weaning,
profound changes occur in the islet macrophage, as was evident by MHC-II expression. This occurs at a time when the
islet is subjected to more demands for growth as well as to a
new intestinal flora. It is possible that the islet macrophage
senses systemic inflammation, as suggested by the modulation
of type 1 diabetes by gut flora and systemic infections (Wen et
al., 2008; Christen and von Herrath, 2011; Markle et al., 2013;
Yurkovetskiy et al., 2015).We speculate that through this sensory function, the macrophages play a protective role for the
islets against blood-borne pathogens. Finally, one component
that may contribute to NOD macrophage activation compared with NOD.Rag1−/− mice is the presence of antibodies,
particularly those derived from the mother. Evidence in favor
of this is that the wild-type heterozygote pups born from B

might be a result of synergistic action of adaptive and innate
immune response (T cell and macrophage activation) as opposed to only an innate response in NOD.Rag1−/−. During
diabetogenesis, it is the lymphocytic infiltrate that is most
likely responsible for the cell division and cellular activity signature in whole islets. Activated macrophages are known to
express genes responsible not only for cytokine and chemokine production but also for cell cycle progression and proliferation (Buxadé et al., 2012).
JEM Vol. 214, No. 8

Because NOD macrophage autoimmune activation is
dependent on the presence of the adaptive immune system,
it is likely that there is heterogeneity in immune components
within a single islet or among them, with some affected and
others not. Resolving this will require isolating single macrophages from individual hand-picked islets, a difficult task
given current technologies. However, this will be an important issue to tackle, as it will instruct us as to the nature of the
activation of the earliest sensors of autoimmune diabetes, the
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Figure 6. Inflammatory status of islets before and after treatment with LPS. (A) NOD or NOD.Rag1−/− mouse islet macrophages were isolated and
stained with the intracellular caspase-1 substrate FAM FLICA YVAD-FMK. The black histograms are gated on the CD45-negative fraction of the islets, and
the gray histograms are gated on macrophages as in Fig. S1. Mean fluorescent intensity (MFI) is indicated on the graphs. MFIs for active caspase-1 ranged
from 62.5–102 (mean 72.2) for the CD45neg population and from 388–884 (mean 625) for the F4/80+ population. Data are representative of two or three
independent experiments per group. (B) Islets from 6-wk-old NOD mice were isolated, dispersed, and cultured overnight in chamber slides in the absence
or presence of IL-1β. Cells were then stained with DAPI (blue) and anti-RelA/p65 (red). Cells were imaged by confocal microscopy. Bar, 4 µm. Image is representative of three independent experiments. (C) Expression of inflammatory gene transcripts in macrophages isolated from islets of mice intravenously
injected with LPS. The indicated mice were treated with either PBS (UT) or LPS IV (LPS). Then, islet macrophages were flow-sorted, RNA was isolated, and
qRT-PCR was performed on the indicated markers. Each symbol represents one individually sorted sample. Horizontal bars show the mean. Significance was
tested using the Mann-Whitney U test. *, P < 0.0332; **, P < 0.0021; ***, P < 0.0002. Graphs show all the data from at least three independent experiments
performed in duplicate for each condition.

Figure 7. Single-cell qRT-PCR of islet macrophages reveals NOD heterogeneity. (A) PCA of the
single-cell qRT-PCR results. The samples circled in black
were all Cxcl9+, whereas no Cxcl9+ cells were found in
the rest of the samples. PC, principal component. (B)
Volcano plot of the fold change (FC; log2) expression
between NOD and NOD.Rag1−/− compared with the
ANOVA p-value (log10). Genes in the upper right quadrant had greater than twofold higher expression on
average in NOD versus NOD.Rag1−/− and were significantly differentially expressed by ANOVA at P < 0.01.
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IL-1R deficiency delays progression to diabetes, albeit modestly (Thomas et al., 2004). As for TNF, its effects are pleiotropic but are also under strict control. TNF can affect not
only β cells but also the vascular endothelium and T cells.
In contrast to IL-1β, TNF has complex effects on diabetes
development, most likely on the effector stage of the disease by modifying not only β cells but also T cells (Yang
et al., 1994; Kägi et al., 1999; Pakala et al., 1999; Wu et al.,
2002; Chee et al., 2011).
The data indicate that the islet macrophage is subjected
to stimuli derived from β cells as well as by blood products
(Calderon et al., 2011; Vomund et al., 2015). Therefore, this
leads to a transcriptional program that is complex, representing the diverse stimuli, and these responses need to be integrated. In the absence of macrophages as in the op/op mouse
the development of islets is impaired (Banaei-Bouchareb
et al., 2004). Studies are now under way in our laboratory
to determine the activation state of islet macrophages derived from different strains and ages of mice and under different biological conditions. The islet macrophages of all
strains examined contain macrophages with core features
similar to NOD.Rag1−/−. In contrast, the signature of diabetic inflammation that includes Cxcl9 and other interferon-inducible genes has been found only in NOD, not in any
of the control strains.
Materials and methods
Mice
NOD/ShiLtJ (NOD), NOD.129S7(B6)-Rag1tm1Mom/J (NOD.
Rag1−/−), and B6.NOD-(D17Mit21-D17Mit10)/LtJ (B6.g7)
mice originally obtained from The Jackson Laboratory were
bred and maintained under specific pathogen-free conditions in our animal facility. All experiments were approved
by the Division of Comparative Medicine of Washington
University School of Medicine in St. Louis (Association for
Assessment and Accreditation of Laboratory Animal Care, accreditation number A3381-01).
Transcriptional signatures of islet macrophages | Ferris et al.
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macrophage, as well as the distribution of islet involvement
in the autoimmune process. Thus, intervention and identification of those who will progress to diabetes must be done
much earlier than diagnosis to intervene and prevent diabetes.
The islet macrophages express IL-1β and TNF at the
steady state. Expression of IL-1β and TNF (and other cytokines) is a complex process (Aggarwal, 2003; Dinarello, 2009;
Pasparakis, 2009). It involves several transcriptional regulators that modulate the level and time of expression of the
gene (Foster et al., 2007; Amit et al., 2009; Yosef and Regev,
2011, 2016; Kotas and Medzhitov, 2015). This regulation is
of particular relevance. As noted earlier, Atf3 is expressed by
the macrophages, indicating a degree of regulation of TLR
signaling. Regarding IL-1β, we find an intermediate expression of active caspase-1 but failed to detect RelA by nuclear
staining in the β cells. However, we may well be missing a
low level of activation and are guarded in concluding a lack
of IL-1β signaling in the β cell. Indeed, it is still likely that
there is a level of homeostatic role for IL-1R signaling in
endocrine function. For example, the p85α component of
the PI3 kinase is activated by IL-1R signaling (Reddy et al.,
1997). Deficiency of p85α leads to reduced insulin secretion
after glucose challenge (Terauchi et al., 1999). Also, IL-1β
treatment of islets instigates down-regulation of the glucose transporter GLUT2 and glucokinase (Park et al., 1999).
Finally, IL-1R1-deficient mice develop late-onset obesity
(García et al., 2006). In sum, IL-1 production by the islet
macrophage may be one component in its general role as a
modulator of glucose homeostasis influencing the pancreas,
fat depots, and central nervous system (del Rey et al., 2006;
Dror et al., 2017). Concerning its role in the autoimmune
process, much has been discussed on IL-1’s role in diabetes
initiation, largely on the basis of the harmful effects of IL-1
on long-term cultures of β cells (Mandrup-Poulsen et al.,
2010). However, a role in diabetes progression in the NOD
mouse model is not evident. Genetic ablation of caspase-1
does not alter diabetes development (Schott et al., 2004).

Antibodies
The following antibodies were purchased from BioLegend:
FITC/PE/PerCP-Cy5.5 anti-B220 (RA3-6B2), PE-Cy7 anti-CD11b (M1/70), PE/APC-Cy7 anti-CD11c (N418), PE/
APC anti-CD274 (10F.9G2), PE-Cy7 anti-CD4 (RM4-5),
APC-Cy7 anti-CD44 (IM7), BV510/APC anti-CD45 (30F11), FITC anti-CD53 (OX-79), FITC/PerCP-Cy5.5 anti-CD8a (53-6.7), PE-Cy7 anti-CD83 (Michel-19), FITC/
APC anti-F4/80 (BM8), and APC anti-TNF (MP6-XT22).
The following antibodies were purchased from eBioscience:
fixable viability dye eflour780 and PerCP efluor710 proIL-1β
(NJTEN3). The following antibodies were purchased from
BD: FITC/APC anti-CD3e (145-2C11), PE anti-IFNγ
(XMG1.2), and PE anti-TLR7 (A94B10). Pacific Blue I-Ag7
(AG2.42.7) was made in our laboratory (Suri et al., 2002).

Intravenous LPS injection
NOD and NOD.Rag1−/− mice were intravenously injected
with 100 ng LPS in 0.1 ml PBS. Mouse islets were harvested
3 h later and dispersed, and macrophages were sorted using
the FACSAria II (BD) after staining with antibodies to CD45,
CD3, CD19, F4/80, and I-Ag7.
RNA isolation and real-time PCR
Sorted cell RNA was isolated using the Ambion RNAqueous-Micro kit (Thermo Fisher Scientific) following the
manufacturer’s instructions. RNA was quantified by OD260
using NanoDrop (Thermo Fisher Scientific). cDNA was
synthesized using iScript Reverse Transcription Supermix
for qRT-PCR (Bio-Rad Laboratories). qRT-PCR was performed using the 5′ nuclease (TaqMan) chemistry using
JEM Vol. 214, No. 8

RNASeq analysis
Library preparation was performed with 1–50 ng total RNA;
integrity was determined using an Agilent Bioanalyzer (Agilent Technologies). Double-stranded cDNA was prepared
using the SeqPlex RNA Amplification kit (Sigma-Aldrich)
per the manufacturer’s protocol. cDNA was blunt ended, had
an adenosine added to the 3′ ends, and then had Illumina
sequencing adapters ligated to the ends. Ligated fragments
were then amplified for 12 cycles using primers incorporating unique index tags. Fragments were sequenced on an Illumina HiSeq-2500 using single reads extending 50 bases. All
RNASeq work was performed by the Genome Technology
Access Center at Washington University School of Medicine.
We assessed the mean quality of sequencing reads for
base pair positions in each sample using the fastqc utility from
fastq-tools (Droop, 2016). Samples with a quality score less
than 25 (Sanger/Illumina 1.9 encoding) across all bases were
truncated using the fastx_trimmer utility, removing base pairs
from the end of each read in the library. All libraries were
aligned to the GRCm38.p4 assembly of the mouse genome
using the STAR aligner (Dobin et al., 2013) with GEN
CODE version M7 (Harrow et al., 2012) transcripts included
into the pregenerated reference. We generated raw counts of
the number of tags on each gene by using htseq-count utility
from the HTseq package (Anders et al., 2015). GENCODE
version M7 (with -t exon option) was used as a reference
GTF. The DESeq2 package (version 1.6.3; Love et al., 2014)
was used to detect differentially expressed genes between the
analyzed conditions (output with P < 0.05 and a Benjamini-Hochberg FDR of 5% was used). Variance between samples was stabilized for the purposes of hierarchical clustering
and PCA to address the problem of heteroscedasticity (dependence of variance on the mean counts). Pathways analysis
was done using the Broad Institute’s GSEA software (Subramanian et al., 2005). All heat maps are in log2 scale.
LPS, TNF, and IL-1 signature analysis
The LPS signature consists of genes up-regulated in macrophages treated with LPS for 40 min when compared with
untreated macrophages at P < 0.05, log fold change >1
(GSE14769). The IL-1 signature consists of genes up-regulated in human monocyte-derived macrophages 4 h after
stimulation with IL-1 compared with control cells (GSE8515,
P < 0.05, log fold change >0.7). The donor effect for the
GSE8515 data set was corrected with ComBat (Johnson et
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Flow cytometry and cell sorting
Islets were harvested as described previously (Calderon et
al., 2015) and dispersed using Cell Dissociation Solution
Non-Enzymatic (Sigma-Aldrich) for 5 min at 37°C. PLNs
and lungs were harvested, finely chopped with scissors, placed
in DMEM (Thermo Fisher Scientific) containing 125 μg/
ml Liberase TL (Roche) and 50 μg/ml DNase I, grade II
(Roche), and incubated at 37°C for 30 min and dispersed via
gentle agitation. Single-cell suspensions incubated in PBS, pH
7.4 (Thermo Fisher Scientific) having 1% BSA (Sigma-Aldrich), and 50% of 2.4G2 conditioned DMEM at 4°C for
15 min to block Fc receptors. Cells were stained with fluorescently labeled antibodies and sorted using a FACSAria
II or analyzed using the FACSCanto II (BD). Macrophages
were sorted on the basis of their expression of CD45, F4/80,
and I-Ag7. DCs were selected on the basis of their expression
of XCR1. In all cases CD3e+ and CD19+ events were eliminated from the sort (dump gated). For cell sorting experiments, ∼500–5,000 macrophages were isolated from 6–10
mice, and this represented 1 biological sample in our analysis.
At least three samples were used for each population studied
by RNASeq analysis. All flow cytometry data were analyzed
using FlowJo software version 10.2 (Tree Star).

iTaq Universal Probes Supermix (Bio-Rad Laboratories).
The 18S ribosomal RNA probe was obtained from Thermo
Fisher Scientific, and all other primers and probes were designed and obtained from IDT DNA. All quantitative PCRs
were performed on a StepOnePlus Real-Time PCR system
(Thermo Fisher Scientific) running StepOne 2.3 Software
(Thermo Fisher Scientific). Quality control was performed
by the StepOne 2.3 software. RT-PCR data analysis was done
using Excel (Microsoft).

al., 2007). The limma package was used for differential expression analysis of microarray data (Ritchie et al., 2015). The
TNF signaling gene set was taken from the Broad Institute
Molecular Signatures Database (MSigDB) hallmark gene sets
(Hallmark TNF signaling via NF-κB). The ImmGen dataset
was downloaded from GEO (GSE15907; Heng et al., 2008).

Immunofluorescence microscopy
For nuclear RelA detection, islets from 6-wk-old NOD females were isolated and dispersed as described previously.
Dispersed cells were placed in chamber slides and incubated
at 37°C overnight in 20 ng/ml IL-1β (PeproTech) DMEM
(Thermo Fisher Scientific) supplemented with 10% FGE
(Healthcare Life Sciences) or in DMEM 10% FBS alone
(Rütti et al., 2016). Cells were washed with 1% BSA in
PBS and fixed and permeabilized using the BD Fix/Perm
kit according to the manufacturer’s instructions. Cells were
stained with NF-κB p65 (D14E12) XP rabbit mAb (Cell
Signaling Technology) overnight at 4°C. Cells were washed
twice with PBS and stained with Alexa 488 anti-rabbit IgG
F(ab')2 (Cell Signaling Technology) for 2 h at room temperature. After washing with PBS, the chamber was removed, and
Prolong Gold Anti-Fade Reagent with DAPI (Cell Signaling
Technology) was applied. Slides were imaged using a Leica
SPE confocal microscope.
For pancreas immunofluorescence, frozen sections from
each tissue were cut on a cryotome at 10 μm. Sections were
fixed for 5 min in ice-cold acetone. Then the sections were
blocked with Cas-Block (Thermo Fisher Scientific) following the manufacturer’s instructions. The sections were then
stained with PE anti-B220 (RA3-6B2), PE anti-Siglec H
(551), or PE anti-Ly6G (1A8; eBioscience) and polyclonal
guinea pig anti-insulin (Thermo Fisher Scientific) for 1 h at
room temperature. Sections were washed three times with
PBS and then stained with goat anti–guinea pig Alexa-488
(A11073; Thermo Fisher Scientific) for 1 h at room temperature. Background autofluorescence was quenched with 70%
ethanol supplemented with 0.5% Sudan Black B (SigmaAldrich) for 2 min at room temperature and washed with PBS.
Nuclei were stained with bisBenzimide H 33258 (Sigma2382

Active caspase-1 detection
Islets were isolated and dispersed as described previously. Cells
were incubated for 30 min at 37°C with the fluorescent inhibitor probe FAM-YVAD-FMK (Immunochemistry Technologies) to label active caspase-1 enzyme. Cells were washed and
stained for cell surface antigens, acquired using a FACSCanto
II flow cytometer, and analyzed using FlowJo software.
Single-cell sorting and quantitative PCR
Islet macrophages were isolated, stained, and single-cellsorted into 96-well plates containing 5 μl Cellsdirect 2X
Reaction Mix (Thermo Fisher Scientific) and 0.1 μl RNase
inhibitor (SUP
ERase-In; Thermo Fisher Scientific) per
well. For reverse transcription and specific cDNA preamplification, all the 96 20× Taqman assays (Fig. S5; IDT DNA)
were mixed and diluted to 0.2×. Subsequently, 2.5 μl of
the 0.2× Taqman assay mix, 0.2 μl of the SuperScript III
RT/Platinum Taq (Thermo Fisher Scientific), and 1.2 μl
PCR-certified water (Thermo Fisher Scientific) were added
together to the sorted single cells. Reverse transcription (15
min at 50°C) was performed, followed by Taq activation (2
min at 95°C) and 18 cycles of cDNA preamplification (each
cycle: 15 s at 95°C, 4 min at 60°C). The resulting cDNA
product was diluted with PCR-certified water (1:5) and
submitted for single-cell quantitative PCR using the Biomark HD system (Fluidigm).
Data availability
RNAseq data are available at the Gene Expression Omnibus
under accession no. GSE100067.
Online supplemental material
Fig. S1 shows the gating strategy for the isolated cells, expression of MHC on macrophages from ImmGen, and flow
cytometry of cell surface markers on islet macrophages.
Fig. S2 shows immunofluorescence of pancreas and lymphoid structures. Fig. S3 shows different islet isolation techniques and outcomes. Fig. S4 shows Pearson correlation,
heat maps, and gene set enrichment analysis. Fig. S5 shows
single-cell islet macrophage qRT-PCR data. Table S1, included in a separate Excel file, shows the normalized gene
counts for the dataset.
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Intracellular flow cytometry
Dispersed islet or PLN cells were placed at 37°C in DMEM,
10% FBS (GE Healthcare), and 10 μg/ml Brefeldin A for 4 h.
As a positive control for activation, samples were pulsed with
100 ng/ml PMA (Sigma-Aldrich) and 500 ng/ml ionomycin
(Sigma-Aldrich). Cells were washed with PBS, 1% BSA, cell
surface stained with fluorescent antibodies for 30 min at 4°C,
and fixed with PBS and 2% formaldehyde (Sigma-Aldrich)
for 15 min at 4°C. Cells were washed with PBS and 1% BSA,
incubated with 2% saponin (Sigma-Aldrich) and PBS for 5
min at 4°C, and then with fluorescent antibodies recognizing
intracellular proteins for 30 min at 4°C. Cells were washed
with 2% saponin and PBS and then with PBS and 1% BSA.
Flow cytometry was performed using a FACSCanto II.

Aldrich) at a concentration of 1 μg/ml in water for 5 min at
room temperature and washed three times with PBS. Sections
were mounted with PBS containing 50% glycerol and visualized via an Olympus BX51 microscope.
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Figure S1. Analysis of islet macrophages. (A) Flow cytometry gating strategy for sorting of macrophages from 3-wk-old mice. Cells were gated on the
basis of forward and side scatter, single cells, CD45 expression, MHC-II, and F4/80 expression. Flow cytometry gating strategy of lung macrophages (B)
and PLN XCR1+ DC (C) populations. Lung macrophages were gated on FSC/SSC, singlets, live dead, CD45, CD11c, F4/80, and MHC-II expression. XCR1+ DCs
were gated on FSC/SSC, singlets, CD45, CD11c, MHC-II, CD11b, CD172a, CD103, and XCR1. (D) Expression of I-Ag7 on CD45+ CD11c+ F4/80+ macrophages
isolated from islets of 2-wk-old and 4-wk-old NOD female mice. (E) Expression of MHC-II complex genes, including the master regulator Ciita by different
macrophage populations, on the basis of the ImmGen dataset (GSE15907). (F) Flow cytometry of CD45+ CD11c+ I-Ag7+ NOD macrophages examining for
CD44, CD53, CD83, and TLR7.
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Figure S2. Immunofluorescence of pancreas and lymphoid tissue. (A, C, and E) Pancreatic sections and (B) splenic sections or (D and F) peripancreatic
lymphoid aggregates (LA) were stained with anti-insulin (β cells) and (A and B) Siglec H (pDCs), (C and D) B220 (B cells), or (E and F) Ly6G (neutrophils). All
sections were nuclear-stained with bisbenzimide. (G) The indicated number of islets were scored for the presence of either B220+, 1A8 (Ly6G)+, or SiglecH+
cells. Results were obtained from NOD mice at 3 wk and C57BL/6 mice at 8 wk of age (three mice for each).
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Figure S3. Imaging of isolated islet preparations. (A and B) C57BL/6J and (C and D) NOD pancreata were digested without hand picking and imaged.
(E and F) NOD pancreata were digested, hand-picked under a dissection microscope, and imaged. All islet preparations were stained with dithizone to allow
visual separation of islets from the acinar or lymphoid aggregate structures that associate with pancreas digestion preparations. Arrows indicate contaminating acinar or leukocytic aggregate structures.
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Figure S4. There are two clusters of genes up-regulated in islet NOD macrophages compared with islet NOD.Rag1−/− macrophages. (A) Pearson’s correlation between all samples on the basis of genes, differentially up-regulated in NOD versus NOD.Rag1−/− islet macrophages with P ≤ 0.05, and
maximum likelihood estimate–moderated fold change ≥2. Heat maps of (B) cluster I and (C) cluster II genes. (D) GSEA plots of lamina propria, serosal, and
CD11b+CD103neg lung macrophages comparing with other macrophages from ImmGen dataset, on the basis of LPS signature. ES, enrichment score.
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Figure S5. Heat map of single islet macrophage qRT-PCR data. Single-cell qRT-PCR data for NOD and NOD.Rag1−/− macrophages were hierarchically
clustered using Pearson’s correlation. (A) Genes selected as significant in Fig. 7 B and (B) all genes were plotted by hierarchical clustering using Pearson’s
correlation for grouping and global Z score for scaling. The key on the bottom of the heat map indicates the cell type examined.

Table S1, included in a separate Excel file, is a gene expression table of islet and lung macrophages and NOD PLN DCs.
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